AI for meta-analysis refers to machine learning and language model tools that assist the quantitative pooling of results across studies: identifying eligible trials, extracting effect estimates and variances, generating synthesis code, and checking the resulting model for errors.
The appeal is arithmetic: screening and extraction absorb most of the labor in a research synthesis project, and both are pattern-recognition tasks. The constraint is that the decisions carrying the most weight, such as which studies are comparable enough to pool, remain judgment calls current tools cannot make defensibly.
A meta-analysis is the statistical component of evidence synthesis: it combines effect estimates from multiple studies into a single pooled estimate with a confidence interval. Each study is weighted, typically by the inverse of its variance, so larger and more precise trials contribute more.
It is not a synonym for systematic review. A systematic review is the full method of locating, appraising, and synthesizing evidence. A meta-analysis is one possible output of that method, appropriate only when the included studies measure comparable populations, interventions, and outcomes. Pooling without that comparability produces a precise number that means nothing.
Effect sizes and weighting. Every study is converted to a common metric: risk ratio, odds ratio, standardized mean difference, or correlation. Inverse-variance weighting then determines each study's influence on the pooled estimate.
Fixed effect versus random effects model. A fixed effect model assumes one true underlying effect and treats variation as sampling error. A random effects model assumes the true effect varies across settings and estimates that distribution. Random effects is the default for most clinical and behavioral syntheses because homogeneity is rarely credible.
Heterogeneity. I-squared, tau-squared, and Cochran's Q quantify dispersion across studies. High heterogeneity does not invalidate a synthesis, but it changes what the pooled estimate means, which is why prediction intervals often communicate more than the confidence interval.
The forest plot. A forest plot displays each study's estimate, interval, and weight alongside the pooled diamond. Reading one properly reveals whether the result is driven by a single large trial or supported across the evidence base.
Search and screening are the most mature applications. Active learning models rank abstracts by predicted relevance, and semantic matching catches conceptually eligible studies that keyword strings miss.
Extraction is where current gains are largest. Language models pull sample sizes, means, standard deviations, and event counts from methods sections and structured tables at a speed no human team matches, then flag conflicts between the abstract and the results. Some tools generate the analysis code directly for R's metafor or a comparable package.
What AI does reliably: locating candidate studies, standardizing extracted fields, detecting reporting inconsistencies, and drafting synthesis summaries. What it does not: extract numbers from figures, resolve unit-of-analysis issues in cluster or crossover designs, or decide two interventions are similar enough to combine. Extraction accuracy still requires verification against source PDFs, which is why precision matters more than coverage in any tool evaluation.
Pooling biased studies produces a biased estimate with a narrower interval, and no tool corrects for this. Risk of bias can be pre-screened by a model, but the judgments driving it, such as whether allocation concealment was adequate, depend on reading what authors did not say.
Publication bias is worse. Funnel plot asymmetry and trim-and-fill are detection heuristics, not corrections, and both perform poorly below ten studies. AI cannot recover unpublished nulls that were never registered, the largest single distortion in most literatures.
Clinical heterogeneity is the remaining gap. Deciding that a six-week trial in adults and a twelve-month trial in adolescents address the same question is a domain judgment. Automated pipelines pool anything metrically compatible, which is how statistically clean and clinically meaningless results get published. A validated quality metric applied to the inputs matters more than model sophistication.
Check the protocol first: an unregistered synthesis, or one whose outcomes shifted after the search, invites selective reporting. Then check heterogeneity, reading the prediction interval rather than the confidence interval when I-squared exceeds roughly 50 percent.
Look at the risk-of-bias profile of the included studies and whether a sensitivity analysis restricted to low-risk trials preserves the effect. Confirm the estimate is not carried by one dominant trial. Finally, look for a GRADE certainty rating: a pooled estimate rated low or very low certainty is a hypothesis, not a finding.